This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Prana Biotechnology Ltd (PRAN)

NASDAQ: Health Care

Company Cash Flow
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Cash Flow From Operating Activities
Net Income (Loss) -7.23M -5.37M -6.87M -4.17M
Operating Gains/Losses -139.00 780.00 169.21K 1.71K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.83M -1.58M -2.72K -254.00
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets -40.42K 22.44K 1.48M -1.10M
(Decrease) Increase In Payables 758.13K -446.28K 165.84K 544.15K
(Decrease) Increase In Other Current Liabilities -16.24K 52.06K 0.00 0.00
(Increase) Decrease In Other Working Capital 46.00K 46.48K -3.56K 71.72K
Other Non-Cash Items 909.86K 244.04K 154.51K 620.81K
Net Cash From Continuing Operations -7.38M -7.01M -4.87M -4.00M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -7.38M -7.01M -4.87M -4.00M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -20.41K -27.41K -14.63K -19.26K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -5.71K 0.00 -2.86K 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -26.12K -27.41K -17.49K -19.26K
Issuance of Debt 312.70K 0.00 370.86K 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 15.09M 3.94M 9.14M 5.10M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -942.54K -226.81K -601.74K -292.40K
Net Cash From Financing Activities 14.46M 3.71M 8.91M 4.81M
Effect of Exchange Rate Changes 99.90K 50.05K -159.81K -1.71K
Net Change in Cash & Cash Equivalents 7.15M -3.28M 3.86M 783.85K
PRAN News

PRAN Prana Biotechnology Ltd

Analysts Ratings for PRAN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PRAN ANALYST REPORT

Brokerage Partners

PRAN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs